Capsida Biotherapeutics - Crunchbase Company Profile & Funding

Q: Who invested in Capsida Biotherapeutics?

Capsida Biotherapeutics has 3 investors including AbbVie And Westlake Village BioPartners.

Q: How much funding has Capsida Biotherapeutics raised to date?

Capsida Biotherapeutics has raised obfuscated.

Overview

Capsida Biotherapeutics

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Capsida Biotherapeutics

CB Rank

18455

Capsida Biotherapeutics is a biotechnology company that specializes in tackling monogenetic and sporadic CNS and non-CNS disorders.

Founded

obfuscation

Private

Corporate Round

Newbury Park, California, United States

101-250

capsida.com

Biotechnology

Genetics

Health Care

Funding Rounds

Corporate Round

OBF

obfuscation

Series A

OBF

obfuscation

Corporate Round

OBF

obfuscation

Key People

Susan Catalano: Chief Scientific Officer
Past Role: Cognition Therapeutics, Co-Founder & Chief Science Officer
Rob Murphy: Chief Manufacturing and Quality Officer

Details

Sub-Organization of

Capsida Biotherapeutics

Legal Name

Capsida Biotherapeutics Inc.,

Also Known As

Capsida

Operating Status

Active

Company Type

For Profit

Founders

Nicholas Flytzanis, Nick Goeden, Viviana Gradinaru

About the Company

Capsida is a biotechnology company that specializes in tackling monogenetic and sporadic CNS and non-CNS disorders. It features a proprietary adeno-associated virus (AAV) engineering platform that generates capsids optimized to target specific tissues and cells in the diseased organ.

Contact Email

info@capsida.com

Predictions & Insights

Growth Insight

See this Growth Insight

Capsida Biotherapeutics is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Products & Services

CAP-002

An intravenously administered gene therapy for STXBP1 developmental and epileptic encephalopathy (STXBP1-DEE) designed to cross the blood-brain barrier and target neurons while limiting off-target effects.

CAP-002

Research & Development

Capsida Biotherapeutics is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Corporate Round - Capsida Biotherapeutics	1	obfuscated obfuscation	AbbVie	Corporate Round
obfuscated obfuscation	Corporate Round - Capsida Biotherapeutics	1	obfuscated obfuscation	AbbVie	Corporate Round
obfuscated obfuscation	Corporate Round - Capsida Biotherapeutics	1	obfuscated obfuscation	AbbVie	Corporate Round
obfuscated obfuscation	Corporate Round - Capsida Biotherapeutics	1	obfuscated obfuscation	AbbVie	Corporate Round
obfuscated obfuscation	Corporate Round - Capsida Biotherapeutics	1	obfuscated obfuscation	AbbVie	Corporate Round

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Corporate Round - Capsida Biotherapeutics	1	obfuscated obfuscation	AbbVie	Corporate Round
obfuscated obfuscation	Corporate Round - Capsida Biotherapeutics	1	obfuscated obfuscation	AbbVie	Corporate Round
obfuscated obfuscation	Corporate Round - Capsida Biotherapeutics	1	obfuscated obfuscation	AbbVie	Corporate Round
obfuscated obfuscation	Corporate Round - Capsida Biotherapeutics	1	obfuscated obfuscation	AbbVie	Corporate Round
obfuscated obfuscation	Corporate Round - Capsida Biotherapeutics	1	obfuscated obfuscation	AbbVie	Corporate Round

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
AbbVie	Yes	Corporate Round - Capsida Biotherapeutics	—
AbbVie	Yes	Corporate Round - Capsida Biotherapeutics	—
AbbVie	Yes	Corporate Round - Capsida Biotherapeutics	—
AbbVie	Yes	Corporate Round - Capsida Biotherapeutics	—
AbbVie	Yes	Corporate Round - Capsida Biotherapeutics	—